StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report published on Wednesday morning. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Trading Up 1.5 %

Shares of TTOO opened at $0.54 on Wednesday. The stock has a 50-day moving average price of $1.05 and a 200-day moving average price of $3.17. T2 Biosystems has a 12-month low of $0.42 and a 12-month high of $8.38.

Institutional Trading of T2 Biosystems

A hedge fund recently raised its stake in T2 Biosystems stock. Virtu Financial LLC increased its position in T2 Biosystems, Inc. (NASDAQ:TTOO) by 29.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,096 shares of the medical equipment provider’s stock after buying an additional 3,018 shares during the quarter. Virtu Financial LLC owned 0.24% of T2 Biosystems worth $39,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 23.18% of the stock is currently owned by hedge funds and other institutional investors.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.